This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fommei, E. Articles by Donato, L. Search for Related Content PubMed PubMed Citation Articles by Fommei, E. Articles by Donato, L.

Hypertension, Vol 10, 212-220, Copyright © 1987 by American Heart Association

ARTICLES

Renal scintigraphic captopril test in the diagnosis of renovascular hypertension

E Fommei, S Ghione, L Palla, F Mosca, M Ferrari, C Palombo, S Giaconi, P Gazzetti and L Donato

Angiotensin converting enzyme (ACE) inhibitor-induced renal failure has been reported in bilateral renal artery stenosis and in stenosis in solitary kidneys, but not in unilateral renal artery stenosis. In these patients, however, a functional impairment of the kidney ipsilateral to the stenosis can often be detected after ACE inhibition by scintigraphic techniques employing glomerular radionuclide tracers like 99mTc-diethylenetriamine pentaacetic acid (DTPA). Dynamic renal scintigraphy with 99mTc-DTPA before and 1 hour after administration of captopril, 25 mg (renal scintigraphic captopril test; RSCT), was performed in a selected series of 39 hypertensive subjects with suspected renovascular hypertension. Changes in glomerular filtration rate induced by captopril on the individual kidney were estimated by assessing the early (120-180 seconds) DTPA uptake by the kidney. Values were expressed as the ratio between the kidney with the lower uptake and the contralateral one in 34 patients and as the ratio of the kidney counts to the injected dose in five patients with solitary kidneys, aortic coarctation, or both. Compared with precaptopril values, postcaptopril uptake decreased markedly in 14 subjects (-62.42 +/- 30.94 [SD]%; range, -25 to -100%) and decreased modestly or even increased in the other 25 (+0.57 +/- 9.83%; range, +28 to -13%). Of the 14 subjects considered to be RSCT-positive diagnostic workup revealed either established (10) or strongly suspected (2) renal artery stenosis in 12 and aortic coarctation in 2 subjects. In another patient with established renovascular hypertension, results of the RSCT were negative when performed in the supine position but became positive when repeated in the sitting position.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C. J White Non-surgical treatment of patients with peripheral vascular disease Br. Med. Bull., October 1, 2001; 59(1): 173 - 192. [Abstract] [Full Text] [PDF]

				N. Eren, S. Unal, Y. Nisanci, K. Adalet, U. Deligonul, and M. Meric The Value of Captopril Renal Scintigraphy in Assessing the Results of Percutaneous Transluminal Renal Angioplasty and in Following up Renovascular Hypertension--A Case Report Angiology, January 1, 1994; 45(1): 71 - 75. [Abstract] [PDF]

				W. J. Elliott, W. B. Martin, and M. B. Murphy Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension Arch Intern Med, March 22, 1993; 153(6): 755 - 764. [Abstract] [PDF]

				S. J. Mann and T. G. Pickering Detection of Renovascular Hypertension: State of the Art: 1992 Ann Intern Med, November 15, 1992; 117(10): 845 - 853. [Abstract] [PDF]

				D. Kim, D. H. Porter, R. Brown, M. S. Crivello, P. Silva, and B. W.A. Leeming Renal Artery Imaging: A Prospective Comparison of Intra-Arterial Digital Subtraction Angiography with Conventional Angiography Angiology, May 1, 1991; 42(5): 345 - 357. [Abstract] [PDF]

				W. B. White and S. E. Halley Comparative Renal Effects of Intravenous Administration of Fenoldopam Mesylate and Sodium Nitroprusside in Patients With Severe Hypertension Arch Intern Med, April 1, 1989; 149(4): 870 - 874. [Abstract] [PDF]